Profile data is unavailable for this security.
About the company
Masimo Corporation is a global medical technology company that develops and produces a wide range of monitoring technologies, including measurements, sensors, patient monitors, automation and connectivity solutions. The Company’s healthcare products and patient monitoring solutions generally incorporate a monitor or circuit board, proprietary single-patient use or reusable sensors, software and/or cables. It primarily sells its healthcare products to hospitals, emergency medical service providers, home care providers, physician offices, veterinarians, long-term care facilities. Its measurement technologies include Measure-through Motion and Low Perfusion pulse oximetry, known as Masimo Signal Extraction Technology (SET) pulse oximetry, and advanced rainbow Pulse CO-Oximetry parameters such as noninvasive hemoglobin (SpHb), alongside many other modalities, including brain function monitoring, hemodynamic monitoring, regional oximetry, capnography and gas monitoring, and others.
- Revenue in USD (TTM)1.72bn
- Net income in USD-203.80m
- Incorporated1996
- Employees3.60k
- LocationMasimo Corp52 DiscoveryIRVINE 92618United StatesUSA
- Phone+1 (949) 297-7000
- Fax+1 (949) 297-7499
- Websitehttps://www.masimo.com/
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Envista Holdings Corp | 2.62bn | 15.30m | 4.06bn | 12.30k | 295.50 | 1.32 | 31.25 | 1.55 | 0.0836 | 0.0836 | 15.37 | 18.72 | 0.4701 | 4.19 | 6.57 | 213,154.50 | 0.2744 | -2.08 | 0.3233 | -2.53 | 55.55 | 56.91 | 0.5836 | -5.58 | 2.02 | 6.19 | 0.3188 | -- | -2.18 | 1.90 | -1,016.37 | -- | -15.36 | -- |
| Stevanato Group SpA | 1.38bn | 165.55m | 4.29bn | 5.52k | 23.33 | 2.28 | 16.23 | 3.11 | 0.6065 | 0.6065 | 5.05 | 6.20 | 0.5058 | 2.95 | 2.65 | 249,616.90 | 6.08 | 8.02 | 7.63 | 10.94 | 29.27 | 31.01 | 12.01 | 13.24 | 1.30 | 30.00 | 0.2386 | 6.82 | 1.72 | 15.53 | -19.13 | 24.61 | 33.52 | -- |
| Lantheus Holdings Inc | 1.53bn | 167.68m | 4.30bn | 808.00 | 27.24 | 3.84 | 18.52 | 2.82 | 2.38 | 2.38 | 21.90 | 16.88 | 0.7055 | 8.67 | 4.48 | 1,888,531.00 | 7.75 | 9.87 | 10.50 | 11.33 | 62.23 | 60.44 | 10.99 | 12.86 | 2.49 | -- | 0.337 | 0.00 | 18.32 | 34.59 | -4.35 | 58.06 | 29.27 | -- |
| TransMedics Group Inc | 566.35m | 90.47m | 4.43bn | 728.00 | 54.44 | 12.46 | 38.15 | 7.82 | 2.38 | 2.41 | 14.48 | 10.40 | 0.6541 | 4.65 | 6.63 | 777,958.80 | 10.45 | -5.73 | 11.37 | -6.28 | 60.28 | 62.37 | 15.97 | -11.86 | 7.13 | 31.19 | 0.5903 | -- | 82.74 | 79.64 | 241.70 | -- | 279.42 | -- |
| Teleflex Inc | 3.19bn | -327.85m | 4.68bn | 14.10k | -- | 1.22 | -- | 1.47 | -7.35 | -7.36 | 70.55 | 86.48 | 0.4154 | 2.05 | 6.00 | 226,240.30 | -4.27 | 4.58 | -4.69 | 5.01 | 53.67 | 54.77 | -10.28 | 11.38 | 1.53 | 6.78 | 0.4114 | 19.74 | 2.45 | 3.26 | -80.38 | -31.40 | 4.25 | 0.00 |
| Merit Medical Systems Inc | 1.48bn | 118.43m | 4.72bn | 7.40k | 40.76 | 3.09 | 19.30 | 3.20 | 1.95 | 1.95 | 24.37 | 25.80 | 0.5898 | 2.39 | 7.38 | 199,611.90 | 4.73 | 3.49 | 5.17 | 3.93 | 48.47 | 45.37 | 8.02 | 5.65 | 2.86 | 14.41 | 0.324 | 0.00 | 7.89 | 6.40 | 27.48 | 85.69 | -14.13 | -- |
| iRhythm Holdings, Inc | 702.57m | -51.46m | 4.73bn | 2.00k | -- | 38.77 | -- | 6.73 | -1.62 | -1.62 | 22.11 | 3.78 | 0.7377 | 12.04 | 9.15 | 351,286.50 | -5.40 | -20.12 | -6.21 | -24.37 | 70.35 | 68.61 | -7.32 | -23.90 | 4.50 | -- | 0.8418 | -- | 20.13 | 22.50 | 8.20 | -- | 19.06 | -- |
| Caris Life Sciences Inc | -100.00bn | -100.00bn | 6.00bn | -- | -- | 12.53 | -- | -- | -- | -- | -- | 1.70 | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | 9.36 | -- | 0.4404 | -- | 34.67 | -- | 18.22 | -- | -- | -- |
| Bruker Corp | 3.44bn | -23.70m | 6.24bn | 11.40k | -- | 2.55 | 32.34 | 1.81 | -0.1562 | -0.1562 | 22.65 | 16.06 | 0.5481 | 1.44 | 5.23 | 301,763.80 | -0.3554 | 6.80 | -0.4523 | 9.20 | 48.00 | 50.00 | -0.6485 | 9.66 | 0.8877 | 9.34 | 0.4462 | 10.87 | 13.56 | 10.19 | -73.53 | -10.52 | 9.57 | 4.56 |
| Glaukos Corp | 469.82m | -87.61m | 6.52bn | 995.00 | -- | 8.47 | -- | 13.88 | -1.55 | -1.55 | 8.28 | 13.41 | 0.4879 | 1.76 | 6.06 | 472,180.90 | -9.10 | -11.24 | -9.92 | -12.04 | 76.87 | 73.54 | -18.65 | -36.68 | 4.47 | -- | 0.0817 | -- | 21.85 | 10.10 | -8.70 | -- | 5.93 | -- |
| Masimo Corp | 1.72bn | -203.80m | 7.27bn | 3.60k | -- | 8.87 | -- | 4.24 | -3.83 | -10.61 | 31.70 | 15.25 | 0.6993 | 1.70 | 5.09 | 476,416.70 | -8.31 | 3.29 | -10.46 | 3.99 | 54.96 | 53.94 | -11.88 | 4.56 | 1.92 | 5.88 | 0.4084 | 0.00 | 2.26 | 17.43 | -474.11 | -- | -6.75 | -- |
| Avantor Inc | 6.58bn | -82.20m | 7.36bn | 13.50k | -- | 1.32 | 22.59 | 1.12 | -0.1203 | -0.1203 | 9.64 | 8.17 | 0.5364 | 5.58 | 6.07 | 487,051.80 | -0.6706 | 3.94 | -0.7693 | 4.48 | 33.13 | 33.76 | -1.25 | 6.87 | 0.9639 | 3.95 | 0.4092 | 0.00 | -2.64 | 2.35 | 121.58 | -- | 23.59 | -- |
| Repligen Corp | 707.89m | 1.74m | 7.86bn | 1.78k | 5,423.69 | 3.77 | 94.67 | 11.11 | 0.0258 | 0.0258 | 12.55 | 37.01 | 0.246 | 2.00 | 5.09 | 398,138.30 | 0.0604 | 3.28 | 0.063 | 3.70 | 51.59 | 54.24 | 0.2455 | 12.37 | 7.14 | -- | 0.2052 | 0.00 | 0.3285 | 18.61 | -171.68 | -- | 5.25 | -- |
| Bio Rad Laboratories Inc | 2.56bn | -675.90m | 8.06bn | 7.70k | -- | 1.20 | -- | 3.15 | -24.30 | -24.30 | 92.91 | 249.77 | 0.252 | 1.53 | 5.52 | 332,139.60 | -6.66 | 3.00 | -7.01 | 3.15 | 52.42 | 55.37 | -26.43 | 14.51 | 3.94 | 0.2476 | 0.1515 | 0.00 | -3.92 | 2.11 | -189.37 | -- | 13.91 | -- |
| Henry Schein Inc | 12.94bn | 391.00m | 9.06bn | 25.00k | 24.33 | 2.72 | 12.84 | 0.7006 | 3.17 | 3.17 | 104.73 | 28.35 | 1.19 | 4.86 | 7.60 | 517,520.00 | 3.70 | 5.43 | 6.36 | 9.19 | 31.19 | 30.23 | 3.10 | 3.98 | 0.7885 | 6.59 | 0.3872 | 0.00 | 2.71 | 4.88 | -6.25 | -11.06 | 19.66 | -- |
Data as of Feb 06 2026. Currency figures normalised to Masimo Corp's reporting currency: US Dollar USD
60.19%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| Fidelity Management & Research Co. LLCas of 30 Sep 2025 | 6.92m | 12.88% |
| Politan Capital Management LPas of 30 Sep 2025 | 4.59m | 8.55% |
| BlackRock Fund Advisorsas of 30 Sep 2025 | 4.31m | 8.02% |
| The Vanguard Group, Inc.as of 31 Dec 2025 | 3.99m | 7.44% |
| BlackRock Investment Management (UK) Ltd.as of 30 Sep 2025 | 3.09m | 5.75% |
| Massachusetts Financial Services Co.as of 31 Dec 2025 | 2.47m | 4.60% |
| T. Rowe Price Investment Management, Inc.as of 30 Sep 2025 | 2.13m | 3.96% |
| Capital Research & Management Co. (Global Investors)as of 30 Sep 2025 | 1.85m | 3.45% |
| BlackRock Advisors LLCas of 30 Sep 2025 | 1.50m | 2.80% |
| SSgA Funds Management, Inc.as of 30 Sep 2025 | 1.48m | 2.76% |
More ▼
Data from 30 Sep 2025 - 31 Dec 2025Source: FactSet Research Systems Inc.
